Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

MRTX Mirati Therapeutics Inc

58,70

0,00 (0,00%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Mirati Therapeutics Charts.

Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Mirati Therapeutics Charts.

News Mirati Therapeutics Inc

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Freitag 2 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 25 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 23 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Mirati Therapeutics Inc News-Artikel

RSE Archive (GM)

Vontobel Financial Produ...

Societe Generale Effekten

Ensurge Micropower Asa

Vanguard Australian Gove...

Net.r.i.1.9618%

FRCJ25 - 04/2025

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen